The Effects of Erythropoietin on Clinical Disability and Brain Pathology in Patients With Progressive Multiple Sclerosis (EPO-ProgMS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01144117
Recruitment Status : Unknown
Verified May 2010 by Rigshospitalet, Denmark.
Recruitment status was:  Recruiting
First Posted : June 15, 2010
Last Update Posted : August 8, 2011
Danish Research Centre for Magnetic Resonance
Information provided by:
Rigshospitalet, Denmark

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2012
  Estimated Study Completion Date : April 2013